Rejected at 7:19 p.m. Dec, 04, 2025 ] by Ahmed7
Author: mbaroody
Related Note: 1484768435794 1
Rationale for change

Adding crucial piece of information to this card that would have helped distinguish between two answers on UWorld question id: 1443

The question requires us to know that benzos increase the frequency (Choice C) versus duration (Choice B) of chloride channel opening

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#AMBOSS::Bjazck #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::03_Benzodiazepines #AK_Step1_v12::#NinjaNerd::12_Neurology::03_Pathology::10_Febrile_Seizures_(Etiology,_Pathophysiology,_Clinical_Features,_Treatment) #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::06_Sedative-Hypnotics::01_Benzodiazepines_&_Flumazenil #AK_Step1_v12::#UWorld::COMLEX::24049 #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::10_Multiple_Sclerosis::Extra #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::05_Anticonvulsants_II #PANCE::EOR::PSYCH #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::16_Sleep_Physiology::Extra #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#AMBOSS::#Self_Assessment #AK_Step1_v12::#OME::04_Organ_Systems::08_Neuroscience::03_Clincial_Cortex::02_GABA_Receptors_and_Alcohol #AK_Step1_v12::#Pixorize::^Missing_image #PANCE::BEHAVIORAL::substance_use #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::05_Benzodiazepines #AK_Step1_v12::#SketchyPharm::09_Pharmacology_Foundations::06_Pharmacodynamic_Basics::01_Agonists,_Antagonists_&_Allosteric_Modulators #AK_Step1_v12::#UWorld::COMLEX::24554 #AK_Step2_v12::#CMS::Psychiatry::Form_07 #AK_Step1_v12::#UWorld::Step::1443 #AK_Step1_v12::#Bootcamp::Neurology::25_Neurotransmitter_Activity_in_Psychiatric_Disease::02_Acetylcholine,_Dopamine,_Norepinephrine,_Serotonin,_and_GABA #AK_Step1_v12::#Bootcamp::Neurology::11_Conduction_Physiology::04_Ion_Channel_Inhibitors_and_Activators #AK_Step1_v12::#Bootcamp::Neurology::28_Seizures::05_Status_Epilepticus #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::05_Benzodiazepines #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::01_Drugs_for_Epilepsy #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::02_Anxiolytic_and_Hypnotic_Drugs #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#AMBOSS::GnaBuO #AK_Step1_v12::#AMBOSS::g6aF4l #AK_Step1_v12::#NinjaNerd::12_Neurology::03_Pathology::09_Seizures_(Etiology,_Pathophysiology,_Clinical_Features,_Treatment,_Complications/Status_Epilepticus #AK_Step1_v12::#B&B::16_Neuro::01_Introduction_to_Neurology::04_Neurotransmitters #AK_Step1_v12::#NBME::Free120 #AK_Step1_v12::#UWorld::Step::937 #AK_Step2_v12::#AMBOSS::GnaBuO #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::08_Neuroscience::03_Clincial_Cortex::02_GABA_Receptors_and_Alcohol #AK_Step1_v12::#UWorld::Step::11665 #AK_Step2_v12::#SketchyPsych::10_Substance_Use/_Medication_Related_Disorders::01_Substance_Use_Overview #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::03_Benzodiazepines-Function #AK_Step1_v12::#Bootcamp::Neurology::28_Seizures::06_Antiepileptic_Medications #AK_Other::Only_Step_1